Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Bayer has launched a new marketing campaign aimed at encouraging women to understand the risks and benefits of their birth control method, including those offered by Bayer. The drug company boasts the most popular birth control pills on the market – Yaz and Yasmin – which have brought in more than $1.5 billion since 2009. The pills are also bringing something new to Bayer – more than 1,000 lawsuits from women who claim they were not adequately warned by the company of the serious health risks associated with Yaz and Yasmin.

Read the rest of this entry »

As Bayer HealthCare begins defending itself against a flurry of lawsuits citing health problems over its blockbuster birth control pills Yaz and Yasmin, the drug company announced it has received approval from the Food and Drug Administration (FDA) on a new oral contraceptive. Bayer’s Natazia combines the hormones estrogen and progestin in doses that adjust four times throughout a women’s menstruation cycle. Natazia is the first birth control pill to use the four-phase dosing protocol with the added benefit of controlling irregular bleeding better than other pills.

Read the rest of this entry »